Table 2 Phase 1 (clinical survey component) disease characteristics of study subject, by group
User | Unmet demander | Non-demander | P | |
|---|---|---|---|---|
(n = 8) | (n = 10) | (n = 11) | ||
Mean (SD) | Mean (SD) | Mean (SD) | ||
FIS IF (0–21) | 13 (4) | 10 (6) | 13 (4) | 0.354 |
FIS AP (0–30) | 22 (4) | 13 (11) | 18 (8) | 0.161 |
Foot pain VAS (0–100 mm) | 40 (14) | 29 (29) | 36 (23) | 0.488 |
HAQ (0–3) | 1.5 (1.25) | 1 (1) | 1 (0.5) | 0.218 |
HAQ ADL (0–4) | 1.5 (1) | 1 (1) | 1.5 (1) | 0.965 |
HAQ Pain VAS (0–100) | 70 (30) | 40 (32) | 56 (23) | 0.087 |
HAQ Health VAS (0–100) | 51 (33) | 35 (25) | 56 (31) | 0.153 |
Tender joints (0–36) | 5 (4) | 4 (5) | 8 (11) | 0.550 |
Swollen joints (0–36) | 4 (3) | 3 (2) | 5 (5) | 0.987 |
Tender soft tissues (0–14) | 2 (2) | 2 (2) | 3 (3) | 0.848 |
Swollen soft tissues (0–14) | 1 (1) | 0 (0) | 1 (2) | 0.096 |
SI Forefoot (0–24) | 14 (7) | 6 (6) | 11 (7) | 0.053 |
SI Rearfoot (0–14) | 10 (3)† | 5 (2) | 5 (4) ‡ | 0.019 |
SI Total (0–36) | 24 (9) | 11 (6) | 16 (8) ‡ | 0.012 |